You are here

Europe

Europe Advisory Panel Rejects Sarepta’s Duchenne Drug Once Again

Europe Advisory Panel Rejects Sarepta’s Duchenne Drug Once Again

Xconomy

Sarepta Therapeutics

Duchenne Muscular Dystrophy

Flag link:

5th Humira biosimilar approved in EU as market entry nears

5th Humira biosimilar approved in EU as market entry nears

Biopharma Dive

Flag link:

Johnson & Johnson Seeks EU and US Label Expansion for Darzalex

Johnson & Johnson Seeks EU and US Label Expansion for Darzalex

Market Realist

Multiple Myeloma

Flag link:

Half of Europe's clinical trials fail to report results despite EU rule

Half of Europe's clinical trials fail to report results despite EU rule

Reuters

clinical trials

Flag link:

Merck's Keytruda clocks up new win as EU approves chemo cocktail

Merck's Keytruda clocks up new win as EU approves chemo cocktail

Yahoo/Reuters

advanced non-squamous non-small cell lung cancer

Flag link:

Sanofi reaps first fruit of Ablynx buyout with a European OK for its lead rare disease drug

Sanofi reaps first fruit of Ablynx buyout with a European OK for its lead rare disease drug

Endpoints

Flag link:

UK’s drug supply contingency plan for hard Brexit

UK’s drug supply contingency plan for hard Brexit

Pharmaforum

Flag link:

Another Shkreli-like drug price controversy? Leadiant finds itself in the spotlight after 500-fold price hike — FT

Another Shkreli-like drug price controversy? Leadiant finds itself in the spotlight after 500-fold price hike — FT

Endpoints

Leadiant Biosciences

Flag link:

Sanofi’s rare disease drug Cablivi approved in the EU

Sanofi’s rare disease drug Cablivi approved in the EU

Pharmaforum

Flag link:

EC approves GSK's Nucala for kids with severe asthma

EC approves GSK's Nucala for kids with severe asthma

Biopharma Dive

Flag link:

AstraZeneca improves diabetes pen to maintain its market share

AstraZeneca improves diabetes pen to maintain its market share

Pharmaforum

Flag link:

AbbVie braces for impact of Humira biosimilars in Europe

AbbVie braces for impact of Humira biosimilars in Europe

Pharmaforum

Flag link:

RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug

RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug

Xconomy

Flag link:

Novartis announces new €78m plant and 450 new jobs to manufacture Kymriah in EU

Novartis announces new €78m plant and 450 new jobs to manufacture Kymriah in EU

GoinPharma

acute lymphoblastic leukemia

Flag link:

UK rejects Gilead's CAR-T cancer cell therapy as too expensive

UK rejects Gilead's CAR-T cancer cell therapy as too expensive

Reuters

Gilead Sciences

Flag link:

Bayer secures approval in the EU for Xarelto® (rivaroxaban) for patients with coronary or peripheral artery disease

Bayer secures approval in the EU for Xarelto® (rivaroxaban) for patients with coronary or peripheral artery disease

Pipeline Review

Flag link:

European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade

European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade

CP WIre

hepatocellular carcinoma

Flag link:

Jazz hiring 100-plus sales representatives to prep for new narcolepsy and AML launches

Jazz hiring 100-plus sales representatives to prep for new narcolepsy and AML launches

Fierce Pharma

Jazz Pharmaceuticals

Flag link:

Bayer targets COPD in a new discovery alliance with Haplogen, Evotec

Bayer targets COPD in a new discovery alliance with Haplogen, Evotec

Endpoints

Flag link:

Better U.S. Patient Access To Cancer Drugs Comes At A Price

Better U.S. Patient Access To Cancer Drugs Comes At A Price

Forbes

Flag link:

Pages